340B Driving Anti-Competitive Health System Tactics, Says Lawsuit

Jefferson Health building
An independent cancer care practice filed a federal lawsuit against Jefferson Health related to the 340B program.
An independent cancer care practice is suing a Philadelphia health system in federal court over a range of alleged anti-competitive [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arkansas Can Enforce 340B Contract Pharmacy Law, State Attorney Tells Appeals Court

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
An attorney for the state of Arkansas recently told a federal appeals court that the state will enforce its 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sources Cited in Drugmakers’ Brief Question Accuracy in High-Profile 340B Patient Definition Case

Genesis
Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.
Inaccurate points were ascribed to 340B advisers and service providers in a recent legal filing by four drugmakers as part [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Appeals Court Decision May Threaten Some State Health Plan Regulations, 340B Protections

A federal appeals court struck down parts of an Oklahoma PBM law, which could create a legal gray area for certain 340B protections.
A federal appeals court decision striking down parts of an Oklahoma pharmacy benefit manager (PBM) law could jeopardize state laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA to Federal Appeals Court: Arkansas Enforcing 340B Contract Pharmacy Law; Seventh Drugmaker Sues Over IRA

Eighth Circuit Court
PhRMA filed a citation to notify the U.S. Eighth Circuit Court of Appeals in St. Louis that Arkansas is enforcing its 340B contract pharmacy law.
The drug industry group challenging the legality of Arkansas’ 340B contract pharmacy law, notified a federal appeals court that the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Little Chance Congress Clears 340B Overhaul in 2023—Unless Courts Act, Say Lobbyists

Capitol building
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program.
Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023, unless spurred by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Boehringer Ingelheim Sues to Block Medicare Price Negotiations

Boehringer Ingelheim headquarters
Boehringer Ingelheim sued the federal government to block Medicare price negotiations shortly before its diabetes drug was picked for negotiations.
Drug maker Boehringer Ingelheim (BI) sued the federal government to block Medicare price negotiations shortly before the Department of Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Accepts Drug Company Filings in 340B Patient Definition Case

Genesis
Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.
A federal district judge has allowed five major drugmakers to file friend-of-the-court briefs in a lawsuit over patient eligibility to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AstraZeneca Sues to Block Medicare Price Negotiations Over ‘Unintended Consequences’ to Orphan Drug Development

AstraZeneca headquarters
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.
Drugmaker AstraZeneca sued the federal government to block Medicare drug price negotiations on Friday, just days before the government announced [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Center Asks Court to Reject Drug Maker Briefs in Challenge to 340B Patient Definition

Genesis
Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.
A health center challenging the government’s 340B program patient definition in a federal district court recently asked a federal judge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live